发明名称 OPTIMIZED BIO-SYNCHRONOUS BIOACTIVE AGENT DELIVERY SYSTEM
摘要 Optimized bio-synchronous drug delivery begins with establishing a bio-synchronous treatment protocol that incorporates individual temporal and innate biological characteristics into a pharmacological treatment plan. The bio-synchronous treatment protocol is thereafter initiated using bioactive agent delivery device. Bio-synchronous drug delivery includes continual collection of patient data such as physical, psychological, temporal and environmental characteristics. This data is analyzed so to not only determine an initial treatment protocol but to also determining whether modification to the ongoing bio-synchronous treatment protocol is required. And, responsive to determining a modification is required the system modifies the bio-synchronous treatment protocol and use of delivery device. These modifications and treatment protocols can include reactive and proactive psychological support supplied to the patient in a variety of formats.
申请公布号 US2014207048(A1) 申请公布日期 2014.07.24
申请号 US201414156998 申请日期 2014.01.16
申请人 Chrono Therapeutics, Inc. 发明人 DiPierro Guy;Levy Alan Joel
分类号 A61M5/172;A61M37/00;A61N1/30;A61M5/30 主分类号 A61M5/172
代理机构 代理人
主权项 1. A method for optimized bio-synchronous drug delivery, the method comprising: establishing a bio-synchronous treatment protocol; initiating the bio-synchronous treatment protocol wherein the bio-synchronous treatment protocol includes use of a bio-synchronous bioactive agent delivery device; gathering patient data during the bio-synchronous treatment protocol; analyzing gathered patient data; determining based on gathered patient data whether modification to the bio-synchronous treatment protocol is required; and responsive to determining modification to the bio-synchronous treatment protocol is required, modifying the bio-synchronous treatment protocol and use of the bio-synchronous bioactive agent delivery device.
地址 Cambridge MA US